Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Share-based Compensation: 2015-2025

Historic Share-based Compensation for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to $1.7 million.

  • Assembly Biosciences' Share-based Compensation rose 109.54% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 19.20%. This contributed to the annual value of $3.1 million for FY2024, which is 39.05% down from last year.
  • As of Q3 2025, Assembly Biosciences' Share-based Compensation stood at $1.7 million, which was up 100.24% from $834,000 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Share-based Compensation registered a high of $2.0 million during Q4 2022, and its lowest value of -$286,000 during Q1 2021.
  • Moreover, its 3-year median value for Share-based Compensation was $834,000 (2025), whereas its average is $1.0 million.
  • In the last 5 years, Assembly Biosciences' Share-based Compensation tumbled by 105.81% in 2021 and then soared by 604.55% in 2022.
  • Over the past 5 years, Assembly Biosciences' Share-based Compensation (Quarterly) stood at $1.9 million in 2021, then grew by 3.50% to $2.0 million in 2022, then slumped by 52.36% to $959,000 in 2023, then dropped by 21.69% to $751,000 in 2024, then skyrocketed by 109.54% to $1.7 million in 2025.
  • Its Share-based Compensation stands at $1.7 million for Q3 2025, versus $834,000 for Q2 2025 and $712,000 for Q1 2025.